These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 38253973)

  • 21. Public preferences in healthcare resource allocation: A discrete choice experiment in South Korea.
    Bae EY; Lim MK; Lee B; Bae G; Hong J
    Health Policy; 2023 Dec; 138():104932. PubMed ID: 37924559
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparing Discrete Choice Experiment with Swing Weighting to Estimate Attribute Relative Importance: A Case Study in Lung Cancer Patient Preferences.
    Veldwijk J; Smith IP; Oliveri S; Petrocchi S; Smith MY; Lanzoni L; Janssens R; Huys I; de Wit GA; Groothuis-Oudshoorn CGM
    Med Decis Making; 2024 Feb; 44(2):203-216. PubMed ID: 38178591
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation and quantification of treatment preferences for patients with asthma or COPD using discrete choice experiment surveys.
    Svedsater H; Leather D; Robinson T; Doll H; Nafees B; Bradshaw L
    Respir Med; 2017 Nov; 132():76-83. PubMed ID: 29229109
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is Easier Better Than Harder? An Experiment on Choice Experiments for Benefit-Risk Tradeoff Preferences.
    Yang JC; Reed SD; Hass S; Skeen MB; Johnson FR
    Med Decis Making; 2021 Feb; 41(2):222-232. PubMed ID: 33463397
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A community-engaged approach to quantifying caregiver preferences for the benefits and risks of emerging therapies for Duchenne muscular dystrophy.
    Peay HL; Hollin I; Fischer R; Bridges JF
    Clin Ther; 2014 May; 36(5):624-37. PubMed ID: 24852596
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Eliciting Societal Preferences for Weighting QALYs for Burden of Illness and End of Life.
    Rowen D; Brazier J; Mukuria C; Keetharuth A; Risa Hole A; Tsuchiya A; Whyte S; Shackley P
    Med Decis Making; 2016 Feb; 36(2):210-22. PubMed ID: 26670663
    [TBL] [Abstract][Full Text] [Related]  

  • 27. What matters most to patients with multiple myeloma? A Pan-European patient preference study.
    Janssens R; Lang T; Vallejo A; Galinsky J; Morgan K; Plate A; De Ronne C; Verschueren M; Schoefs E; Vanhellemont A; Delforge M; Schjesvold F; Cabezudo E; Vandebroek M; Stevens H; Simoens S; Huys I
    Front Oncol; 2022; 12():1027353. PubMed ID: 36523996
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chronic pain patients' treatment preferences: a discrete-choice experiment.
    Mühlbacher AC; Junker U; Juhnke C; Stemmler E; Kohlmann T; Leverkus F; Nübling M
    Eur J Health Econ; 2015 Jul; 16(6):613-28. PubMed ID: 24950770
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Patient preferences for dry powder inhaler attributes in asthma and chronic obstructive pulmonary disease in France: a discrete choice experiment.
    Hawken N; Torvinen S; Neine ME; Amri I; Toumi M; Aballéa S; Plich A; Roche N
    BMC Pulm Med; 2017 Jul; 17(1):99. PubMed ID: 28683805
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Line of therapy and patient preferences regarding lung cancer treatment: a discrete-choice experiment.
    Janse S; Janssen E; Huwig T; Basu Roy U; Ferris A; Presley CJ; Bridges JFP
    Curr Med Res Opin; 2021 Apr; 37(4):643-653. PubMed ID: 33571024
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Patient Preferences for Preventive Migraine Treatments: A Discrete-Choice Experiment.
    Mansfield C; Gebben DJ; Sutphin J; Tepper SJ; Schwedt TJ; Sapra S; Shah N
    Headache; 2019 May; 59(5):715-726. PubMed ID: 30861110
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Societal perspectives on disease and treatment attributes characterizing rare diseases: a qualitative study from the United States.
    Szabo SM; Audhya IF; Feeny D; Neumann P; Malone DC; Gooch KL
    J Patient Rep Outcomes; 2022 Jan; 6(1):9. PubMed ID: 35072826
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Australian Public Preferences for the Funding of New Health Technologies: A Comparison of Discrete Choice and Profile Case Best-Worst Scaling Methods.
    Whitty JA; Ratcliffe J; Chen G; Scuffham PA
    Med Decis Making; 2014 Jul; 34(5):638-54. PubMed ID: 24713695
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantifying patient preferences for systemic atopic dermatitis treatments using a discrete-choice experiment.
    Boeri M; Sutphin J; Hauber B; Cappelleri JC; Romero W; Di Bonaventura M
    J Dermatolog Treat; 2022 May; 33(3):1449-1458. PubMed ID: 33023361
    [TBL] [Abstract][Full Text] [Related]  

  • 35. How Do Older Adults Consider Age, Life Expectancy, Quality of Life, and Physician Recommendations When Making Cancer Screening Decisions? Results from a National Survey Using a Discrete Choice Experiment.
    Janssen EM; Pollack CE; Boyd C; Bridges JFP; Xue QL; Wolff AC; Schoenborn NL
    Med Decis Making; 2019 Aug; 39(6):621-631. PubMed ID: 31226903
    [No Abstract]   [Full Text] [Related]  

  • 36. Assessing the value of symptom relief for patients with gastroesophageal reflux disease treatment: willingness to pay using a discrete choice experiment.
    Deal K; Marshall D; Dabrowski D; Charter A; Bukoski M; Moayyedi P
    Value Health; 2013 Jun; 16(4):588-98. PubMed ID: 23796293
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Attribute nonattendance in COVID-19 vaccine choice: A discrete choice experiment based on Chinese public preference.
    Xiao J; Wang F; Wang M; Ma Z
    Health Expect; 2022 Jun; 25(3):959-970. PubMed ID: 35049117
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Attribute Selection for a Discrete Choice Experiment Incorporating a Best-Worst Scaling Survey.
    Webb EJD; Meads D; Lynch Y; Judge S; Randall N; Goldbart J; Meredith S; Moulam L; Hess S; Murray J
    Value Health; 2021 Apr; 24(4):575-584. PubMed ID: 33840436
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Older adult patient preferences for the content and format of prescription medication labels - A best-worst scaling and discrete choice experiment study.
    Malhotra R; Suppiah SD; Tan YW; Sung P; Tay SSC; Tan NC; Koh GC; Chan A; Chew LST; Ozdemir S;
    Res Social Adm Pharm; 2023 Nov; 19(11):1455-1464. PubMed ID: 37507340
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Parent preferences regarding stimulant therapies for ADHD: a comparison across six European countries.
    Nafees B; Setyawan J; Lloyd A; Ali S; Hearn S; Sasane R; Sonuga-Barke E; Hodgkins P
    Eur Child Adolesc Psychiatry; 2014 Dec; 23(12):1189-200. PubMed ID: 24443092
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.